Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calsurf for Acute Respiratory Distress Syndrome in Infants
ChiCTR-OPC-17011351Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital, Huazhong University of Science and Technology
- Start
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of calfactant in acute respiratory distress syndrome (ARDS) and pneumonia (2 arms), sponsored by Tongji Hospital, Huazhong University of Science and Technology. Primary endpoints: Blood gas analysis, Complications and 1 more. Planned start May 2017; status: not yet recruiting.
02
Drugs
calfactant
03
Conditions
acute respiratory distress syndrome (ARDS)pneumonia
Beyond the preview
Go deeper on ChiCTR-OPC-17011351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17011351.